Send symptomatic patients to the highest level of staff and have the simpler work done by staff who are paid less. Have the users take their own history, which avoids transcription errors.
Always pilot the change. Have a goal and reward your staff for performance. "Every month we award a £20 voucher. And at every Christmas party, we have staff-nominated Golden Swab Awards in ridiculous categories—it's a great honor to receive a Golden Swab Award."
"It's really difficult to shift social norms," Dr. McCormack noted. "Antibiotic resistance is definitely a potential threat but resistance to change is the greater threat."
"What I love about PrEP is that it's an incentive to bring people into the clinic we may not have seen before and an incentive to engage them in regular testing. It's definitely going to stop HIV increasing at the same rate as the other STIs go up, and it's an opportunity that you cannot ignore. It's an opportunity that Ward Cates would not want you to ignore."
The Ward Cates Memorial Lecture was given to honor Dr. Willard (Ward) Cates Jr., MD, MPH, former CDC epidemiologist who became the agency's director of the Division of Sexually Transmitted Diseases. At the time of his death in March 2016, he was the president emeritus of research at Family Health International (now FHI 360).
Lorraine L. Janeczko, MPH, is a medical science writer who creates news, continuing medical education and feature content in a wide range of specialties for clinicians, researchers and other readers. She has completed a Master of Public Health degree through the Department of Epidemiology of the Johns Hopkins Bloomberg School of Public Health and a Dana Postdoctoral Fellowship in Preventive Public Health Ophthalmology from the Wilmer Eye Institute, the Johns Hopkins University School of Medicine and the Bloomberg School.
DISCLOSURES: Gilead supported all the trials by supplying free drug and a grant for diagnostics and start-up costs of the pilot phase of the PROUD study.
Quotes: audio recording and interview
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.